Articles from BIOTECH Patent News (February 1, 2005)

1-29 out of 29 article(s)

Title	Type	Words
Advanced Biological acquires control of TherapyEdge.		446
Advanced Cell announces ruling on human applications of nuclear transfer, issuance of patent, and intent to appeal adverse ruling on animal claims.		351
Aventis obtains United States patent.	Brief Article	177
Bavarian Nordic announces further investment in smallpox vaccine production and product development in the United States and Europe.		661
Bioaxone obtains United States patent.	Brief Article	98
Cedars-Sinai Medical Center obtains United States patent.	Brief Article	111
Chromos and AppTec announce strategic alliance to provide integrated services for biopharmaceutical manufacturing.		460
Duke obtains United States patent.	Brief Article	174
GenoMed files patent application for two cancer-related genes.		503
GenoMed therapy could reduce healthcare costs.		606
Harvard Medical School and Genomics to launch genotyping study in atherosclerosis with Affymetrix.		905
Invitrogen obtains United States patent.	Brief Article	92
Johns Hopkins obtains United States patent.	Brief Article	114
Kraft obtains United States patent.	Brief Article	185
Millennium announces promising findings from antibody-chemotherapeutic prostate cancer trial.		1845
New York University obtains United States patent.	Brief Article	89
Novogen patent license to Solae transferred to Archer Daniels.	Brief Article	271
Pfizer to acquire Idun.		463
Pharmacy and Therapeutic Advisory Consultancy obtains United States patent.	Brief Article	93
Pioneer Hi-Bred obtains United States patent.		108
Prolexys licenses anti-cancer compounds.		435
Sigma-Aldrich to acquire Proligo group to strengthen genomics research tools portfolio.		631
Sirna Therapeutics granted two key patents on its RNA interference technology.		786
Spectrum announces initiation of Imitrex injection patent challenge.		779
United States patent granted to Cyclacel for cyclin dependent kinase inhibitor series.		899
United Therapeutics granted five-year patent term extension for Remodulin.		119
University of Michigan obtains United States patent.	Brief Article	95
Update on patent ltigation schedule in the United States for Plavix.	Brief Article	114
Viragen reports advancement in avian transgenics biomanufacturing anti-cancer antibody expressed in rooster.		524